
SGLT‑2 inhibitors and Atrial Fibrillation in the Food and Drug Administration Adverse Event Reporting System
The study finding complements available evidence from trials supporting a protective role of SGLT2i against the occurrence of AF.
The study finding complements available evidence from trials supporting a protective role of SGLT2i against the occurrence of AF.
This study demonstrates the existence of gender disparities in post resuscitation care and highlights the need for future qualitative studies focused on decision-making and care being provided in the post-resuscitation phase to narrow gender-based differences in cardiac arrest outcomes.
This study identifies a diagnostic role for broad, multi-phenotype genetic testing in idiopathic SCA survivors who are not routinely considered for genetic testing based on current guidelines
Individuals with similar contemporary SBP may be at different long-term risk for CVD due to differences in their cumulative exposure to SBP.
The study suggest the utility of tilt testing as a method for selecting pacemaker candidates.
Natural premature menopause may represent a risk signal for latent genomic instability and predilection to develop CHIP and CHIP-associated cardiovascular disease.